US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)

4.71

-0.2700-5.42%

Volume:60.86K

Turnover:287.95K

Market Cap:194.04M

PE:-1.84

High:5.07

Open:4.99

Low:4.53

Close:4.98

52wk High:8.79

52wk Low:2.34

Shares:41.20M

Float Shares:30.36M

Volume Ratio:0.51

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5606

EPS(LYR):-3.7669

ROE:-2698.53%

ROA:-268.96%

PB:52.47

PE(LYR):-1.25

Loading ...

Overview Company News Filings

Echo IQ Highlights Market Potential for EchoSolv AS Following Presentation of New Data for Severe Aortic Stenosis (AS) Presented at AHA Scientific Sessions 2025

Notice of General Meeting/Proxy Form-AVR.O

Application for quotation of securities - AVR-AVR.O

Statement of CDIs on issue - AVR-AVR.O

FDA Approves Anteris to Begin PARADIGM Trial for DurAVR Heart Valve

FDA Approves Anteris’s Duravr® Thv Global Pivotal Trial (the “Paradigm Trial”)

THOMSON REUTERS

Notification of cessation of securities - AVR-AVR.O

Anteris Technologies Global Corp-Update on Capital Raising Timetable

THOMSON REUTERS

Update on Capital Raising Timetable-AVR.O

BRIEF-Anteris Technologies Global Corp Says FDA Approves Duravr THV Global Pivotal Trial

Anteris Technologies Global Corp - FDA Approves Duravr Thv Global Pivotal Trial

THOMSON REUTERS

Schedule 14A Preliminary Proxy Statement-AVR.O

Anteris Technologies Global Corp. Announces Date for Upcoming Annual Meeting of Stockholders

Cleansing Notice-AVR.O

Favorable Hemodynamics in Small Annuli Patients at One Year-AVR.O

BRIEF-Anteris Duravr THV Shows Favorable Hemodynamics In Small Annuli Patients With No Valve Mortality At One Year

Anteris Duravr® Thv Demonstrates Favorable Hemodynamics in Small Annuli Patients With No Valve Related Mortality at One Year

THOMSON REUTERS

Anteris Technologies Reports Positive One-Year Results for DurAVR THV in Small Annuli Patients

BRIEF-Anteris Technologies Global Announces $25.2 Mln Placement

Anteris Technologies Global Corp-Proposed Issue of Securities - Avr

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVR\",,,,,undefined,":{"symbol":"AVR","market":"US","secType":"STK","nameCN":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)","latestPrice":4.71,"timestamp":1765823544163,"preClose":4.98,"halted":0,"volume":60861,"delay":0,"floatShares":30362399,"shares":41197570,"eps":-2.560628,"marketStatus":"Trading","change":-0.27,"latestTime":"12-15 13:32:48 EST","open":4.99,"high":5.07,"low":4.5281,"amount":287945.9527104,"amplitude":0.108815,"askPrice":4.73,"askSize":674,"bidPrice":4.7,"bidSize":12,"shortable":3,"etf":0,"ttmEps":-2.560628,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"listingDate":1734066000000,"exchange":"NASDAQ","adjPreClose":4.98,"postHourTrading":{"tag":"盘后","latestPrice":4.98,"preClose":4.98,"latestTime":"18:04 EST","volume":1628,"amount":8107,"timestamp":1765580665816},"volumeRatio":0.511019},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVR\",,,,,undefined,":{"symbol":"AVR","floatShares":30362399,"roa":"-268.96%","roe":"-2698.53%","lyrEps":-3.766913,"volumeRatio":0.511019,"shares":41197570,"dividePrice":0,"high":5.07,"amplitude":0.108815,"preClose":4.98,"low":4.5281,"week52Low":2.34,"pbRate":"52.47","psRate":"90.72","week52High":8.79,"institutionHeld":0,"latestPrice":4.71,"committee":-0.965015,"eps":-2.560628,"divideRate":0,"volume":60861,"delay":0,"ttmEps":-2.560628,"open":4.99,"prevYearClose":5.58,"prevWeekClose":4.98,"prevMonthClose":4.1,"prevQuarterClose":4.5,"fiveDayClose":4.77,"twentyDayClose":3.69,"sixtyDayClose":5.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"AVR","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2025-08-11","symbol":"AVR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2025-05-13","symbol":"AVR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1736398800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVR","date":"2025-12-12","current":-1.839393,"percent":0.3,"low":-4.309469,"twenty":-2.853802,"median":-1.986966,"eighty":-1.657119,"high":-1.284919,"avg":-2.227845,"sd":0.704649,"marketCap":206784230.1},"quantilePoints":[{"date":"2024-12-13","current":-4.309469,"twenty":-3.954542,"median":-3.42215,"eighty":-2.889759,"marketCap":241785702.43},{"date":"2024-12-20","current":-2.805718,"twenty":-4.172089,"median":-3.512177,"eighty":-2.811361,"marketCap":201352959.62},{"date":"2024-12-27","current":-2.583453,"twenty":-3.622571,"median":-2.805718,"eighty":-2.757968,"marketCap":185402037.34},{"date":"2025-01-03","current":-2.649507,"twenty":-3.534256,"median":-2.762782,"eighty":-2.579368,"marketCap":190142423.87},{"date":"2025-01-10","current":-2.852132,"twenty":-3.175408,"median":-2.762782,"eighty":-2.600721,"marketCap":204683859.73},{"date":"2025-01-17","current":-3.002665,"twenty":-2.971604,"median":-2.819825,"eighty":-2.634597,"marketCap":215486892.65},{"date":"2025-01-24","current":-2.851831,"twenty":-2.948519,"median":-2.851981,"eighty":-2.666015,"marketCap":204662263.45},{"date":"2025-01-31","current":-2.906655,"twenty":-2.944586,"median":-2.853802,"eighty":-2.693654,"marketCap":208596707.81},{"date":"2025-02-07","current":-3.031153,"twenty":-3.019758,"median":-2.892021,"eighty":-2.72197,"marketCap":217531318.5},{"date":"2025-02-14","current":-4.028787,"twenty":-3.122985,"median":-2.906655,"eighty":-2.759894,"marketCap":289126773.99},{"date":"2025-02-21","current":-4.026548,"twenty":-3.600492,"median":-2.934832,"eighty":-2.768401,"marketCap":288966072.36},{"date":"2025-02-28","current":-3.495725,"twenty":-3.645669,"median":-2.944494,"eighty":-2.793846,"marketCap":250871469.3},{"date":"2025-03-07","current":-3.832499,"twenty":-3.790793,"median":-2.978055,"eighty":-2.807758,"marketCap":275040122.18},{"date":"2025-03-14","current":-3.416065,"twenty":-3.648727,"median":-3.062965,"eighty":-2.819522,"marketCap":260615031.45},{"date":"2025-03-21","current":-2.912731,"twenty":-3.6348,"median":-3.094777,"eighty":-2.837512,"marketCap":222215144.46},{"date":"2025-03-28","current":-2.210641,"twenty":-3.611075,"median":-2.99036,"eighty":-2.768401,"marketCap":168652007.07},{"date":"2025-04-04","current":-1.681137,"twenty":-3.559327,"median":-2.950896,"eighty":-2.657761,"marketCap":128255615.11},{"date":"2025-04-11","current":-1.42483,"twenty":-3.533246,"median":-2.940881,"eighty":-2.567927,"marketCap":108701753.26},{"date":"2025-04-17","current":-1.381221,"twenty":-3.521148,"median":-2.932645,"eighty":-2.443141,"marketCap":105374733.95},{"date":"2025-04-25","current":-2.267775,"twenty":-3.514553,"median":-2.906655,"eighty":-2.267775,"marketCap":173010794.47},{"date":"2025-05-02","current":-2.264443,"twenty":-3.512177,"median":-2.892021,"eighty":-2.267775,"marketCap":172756626.85},{"date":"2025-05-09","current":-2.138136,"twenty":-3.50581,"median":-2.853802,"eighty":-2.138136,"marketCap":163120562.04},{"date":"2025-05-16","current":-1.930992,"twenty":-3.495725,"median":-2.842881,"eighty":-2.048426,"marketCap":157964762.12},{"date":"2025-05-23","current":-1.529866,"twenty":-3.47072,"median":-2.805718,"eighty":-1.914202,"marketCap":125150696.65},{"date":"2025-05-30","current":-1.846631,"twenty":-3.452168,"median":-2.762782,"eighty":-1.892505,"marketCap":151063610.88},{"date":"2025-06-06","current":-2.0132,"twenty":-3.427608,"median":-2.694374,"eighty":-1.855525,"marketCap":164689842.12},{"date":"2025-06-13","current":-2.055267,"twenty":-3.417377,"median":-2.612233,"eighty":-1.892505,"marketCap":168131158.71},{"date":"2025-06-20","current":-1.715537,"twenty":-3.345636,"median":-2.585759,"eighty":-1.853351,"marketCap":140339523.07},{"date":"2025-06-27","current":-1.809035,"twenty":-3.256784,"median":-2.563535,"eighty":-1.812529,"marketCap":147988126.84},{"date":"2025-07-03","current":-1.627995,"twenty":-3.205309,"median":-2.520408,"eighty":-1.772538,"marketCap":133178156.79},{"date":"2025-07-11","current":-1.530591,"twenty":-3.153512,"median":-2.419568,"eighty":-1.736006,"marketCap":125209987.53},{"date":"2025-07-18","current":-1.4804,"twenty":-3.126561,"median":-2.343221,"eighty":-1.703697,"marketCap":121104101.13},{"date":"2025-07-25","current":-1.412461,"twenty":-3.122985,"median":-2.267775,"eighty":-1.677031,"marketCap":115546339.43},{"date":"2025-08-01","current":-1.474074,"twenty":-3.114482,"median":-2.247212,"eighty":-1.637091,"marketCap":120586665.81},{"date":"2025-08-08","current":-1.590163,"twenty":-3.099273,"median":-2.207904,"eighty":-1.591309,"marketCap":130083291.95},{"date":"2025-08-15","current":-1.578942,"twenty":-3.069327,"median":-2.139819,"eighty":-1.587911,"marketCap":132523707.31},{"date":"2025-08-22","current":-1.545248,"twenty":-3.019758,"median":-2.094237,"eighty":-1.577141,"marketCap":129695762.64},{"date":"2025-08-29","current":-1.570053,"twenty":-2.992821,"median":-2.030879,"eighty":-1.577141,"marketCap":131777665.25},{"date":"2025-09-05","current":-1.677383,"twenty":-2.972718,"median":-1.990098,"eighty":-1.579714,"marketCap":140786140.93},{"date":"2025-09-12","current":-2.10128,"twenty":-2.951274,"median":-1.966995,"eighty":-1.583525,"marketCap":176364641.03},{"date":"2025-09-19","current":-2.245817,"twenty":-2.949708,"median":-2.013266,"eighty":-1.587161,"marketCap":188495913.06},{"date":"2025-09-26","current":-1.786155,"twenty":-2.94477,"median":-2.0132,"eighty":-1.590736,"marketCap":149915580.36},{"date":"2025-10-03","current":-1.836113,"twenty":-2.942772,"median":-1.977162,"eighty":-1.595045,"marketCap":154108633.04},{"date":"2025-10-10","current":-2.052309,"twenty":-2.93715,"median":-1.971576,"eighty":-1.604811,"marketCap":172254407.68},{"date":"2025-10-17","current":-2.083243,"twenty":-2.933957,"median":-1.976752,"eighty":-1.612531,"marketCap":174850695.44},{"date":"2025-10-24","current":-2.461764,"twenty":-2.926913,"median":-1.988526,"eighty":-1.617234,"marketCap":206620780},{"date":"2025-10-31","current":-1.990765,"twenty":-2.911516,"median":-2.002921,"eighty":-1.622674,"marketCap":167088901.63},{"date":"2025-11-07","current":-1.722091,"twenty":-2.905895,"median":-1.990765,"eighty":-1.628785,"marketCap":144538557.11},{"date":"2025-11-14","current":-1.933523,"twenty":-2.902854,"median":-1.988371,"eighty":-1.632206,"marketCap":162284456.32},{"date":"2025-11-21","current":-1.659209,"twenty":-2.898521,"median":-1.985632,"eighty":-1.636747,"marketCap":139901191.46},{"date":"2025-11-28","current":-1.921451,"twenty":-2.881188,"median":-1.981928,"eighty":-1.650736,"marketCap":162012915.47},{"date":"2025-12-05","current":-2.115337,"twenty":-2.867587,"median":-1.982339,"eighty":-1.65233,"marketCap":178360987.03},{"date":"2025-12-12","current":-2.452433,"twenty":-2.853802,"median":-1.986966,"eighty":-1.657119,"marketCap":206784230.1}],"updateTime":1765823568987},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583586898","title":"Echo IQ Highlights Market Potential for EchoSolv AS Following Presentation of New Data for Severe Aortic Stenosis (AS) Presented at AHA Scientific Sessions 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2583586898","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583586898?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:05","pubTimestamp":1762981500,"startTime":"0","endTime":"0","summary":"Investigator-initiated study shows potential for EchoSolv AS to drive improved patient outcomes when used to support cardiologist in identifying severe AS particularly in womenNEDA study of 1.2M patie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3186797/0/en/Echo-IQ-Highlights-Market-Potential-for-EchoSolv-AS-Following-Presentation-of-New-Data-for-Severe-Aortic-Stenosis-AS-Presented-at-AHA-Scientific-Sessions-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","IQ","AS","BK4505","BK4108","BK4526","BK4531","AVR","BK4082","BK4552"],"gpt_icon":0},{"id":"2582079386","title":"Notice of General Meeting/Proxy Form-AVR.O","url":"https://stock-news.laohu8.com/highlight/detail?id=2582079386","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582079386?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:36","pubTimestamp":1762814180,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251110:nASXGjg5Q","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nASX1v1DxW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2581058133","title":"Application for quotation of securities - AVR-AVR.O","url":"https://stock-news.laohu8.com/highlight/detail?id=2581058133","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581058133?lang=en_us&edition=fundamental","pubTime":"2025-11-06 14:34","pubTimestamp":1762410859,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251106:nASX1FyF35","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nASXbDkC4q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2581808456","title":"Statement of CDIs on issue - AVR-AVR.O","url":"https://stock-news.laohu8.com/highlight/detail?id=2581808456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581808456?lang=en_us&edition=fundamental","pubTime":"2025-11-06 08:11","pubTimestamp":1762387917,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251106:nASXb62pf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nASXszhSM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2580629757","title":"FDA Approves Anteris to Begin PARADIGM Trial for DurAVR Heart Valve","url":"https://stock-news.laohu8.com/highlight/detail?id=2580629757","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580629757?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:01","pubTimestamp":1762171278,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp. has received approval from the U.S. Food and Drug Administration  to initiate the PARADIGM global Investigational Device Exemption  clinical trial. The trial will evaluate the safety and effectiveness of the DurAVR Transcatheter Heart Valve  in patients with severe calcific aortic stenosis and is intended to support a future premarket approval  submission. This regulatory milestone also allows Anteris to begin patient recruitment in the United States, following the successful launch and treatment of initial patients in Denmark. The PARADIGM Trial is co-chaired by leading cardiovascular experts from Houston Methodist Hospital, Texas, and Bern University Hospital, Switzerland. No grant or funding was announced for multiple organizations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL8cWvSM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NDAQ","IE00BKPKM429.USD","BK4082","LU2095319765.USD","IE00BGHQF748.EUR","AVR","BK4112","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2580973522","title":"FDA Approves Anteris’s Duravr® Thv Global Pivotal Trial (the “Paradigm Trial”)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580973522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580973522?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171205,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUATSWYQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2580659282","title":"Notification of cessation of securities - AVR-AVR.O","url":"https://stock-news.laohu8.com/highlight/detail?id=2580659282","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580659282?lang=en_us&edition=fundamental","pubTime":"2025-11-03 14:29","pubTimestamp":1762151399,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251103:nASX8mDSpl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nASX8pjVcf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2580263184","title":"Anteris Technologies Global Corp-Update on Capital Raising Timetable","url":"https://stock-news.laohu8.com/highlight/detail?id=2580263184","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580263184?lang=en_us&edition=fundamental","pubTime":"2025-11-03 14:29","pubTimestamp":1762151390,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUE63HLL9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2580265941","title":"Update on Capital Raising Timetable-AVR.O","url":"https://stock-news.laohu8.com/highlight/detail?id=2580265941","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580265941?lang=en_us&edition=fundamental","pubTime":"2025-11-03 14:29","pubTimestamp":1762151390,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251103:nASXZRFwM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nASX3snZZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2580231189","title":"BRIEF-Anteris Technologies Global Corp Says FDA Approves Duravr THV Global Pivotal Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2580231189","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580231189?lang=en_us&edition=fundamental","pubTime":"2025-11-03 06:11","pubTimestamp":1762121463,"startTime":"0","endTime":"0","summary":"BRIEF-Anteris Technologies Global Corp Says FDA Approves Duravr THV Global Pivotal TrialNov 3 (Reuters) - Anteris Technologies Global Corp AVR.O:FDA APPROVES DURAVR THV GLOBAL PIVOTAL TRIALFurther company coverage: AVR.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nFWN3WE00J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR.AU","BK7126","BK7007","AVR","BK4082"],"gpt_icon":0},{"id":"2580316092","title":"Anteris Technologies Global Corp - FDA Approves Duravr Thv Global Pivotal Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2580316092","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580316092?lang=en_us&edition=fundamental","pubTime":"2025-11-03 06:09","pubTimestamp":1762121355,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nFWN3WE00J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2579109120","title":"Schedule 14A Preliminary Proxy Statement-AVR.O","url":"https://stock-news.laohu8.com/highlight/detail?id=2579109120","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579109120?lang=en_us&edition=fundamental","pubTime":"2025-10-31 06:11","pubTimestamp":1761862279,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251030:nASX8T3tyf","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nASXb3FW2F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2579123153","title":"Anteris Technologies Global Corp. Announces Date for Upcoming Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2579123153","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579123153?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:15","pubTimestamp":1761833725,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp. will hold its 2025 Annual Meeting of Stockholders on December 3, 2025, at the InterContinental Brisbane in Queensland, Australia. Among the proposals to be voted on are the approval of adjustments to the exercise price of certain stock options previously granted under the company's Employee Incentive Plan and amendments to the terms of stock options previously granted under the company's 2017 Incentive Plan and 2020 Incentive Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anteris Technologies Global Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission ,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL4ZKZqp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2579316839","title":"Cleansing Notice-AVR.O","url":"https://stock-news.laohu8.com/highlight/detail?id=2579316839","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579316839?lang=en_us&edition=fundamental","pubTime":"2025-10-30 10:17","pubTimestamp":1761790631,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251030:nASX2VXjjY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nASX6x6RRs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2579536919","title":"Favorable Hemodynamics in Small Annuli Patients at One Year-AVR.O","url":"https://stock-news.laohu8.com/highlight/detail?id=2579536919","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579536919?lang=en_us&edition=fundamental","pubTime":"2025-10-29 06:48","pubTimestamp":1761691719,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251028:nASX1SN2KQ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nASX9vsmpy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2579446913","title":"BRIEF-Anteris Duravr THV Shows Favorable Hemodynamics In Small Annuli Patients With No Valve Mortality At One Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2579446913","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579446913?lang=en_us&edition=fundamental","pubTime":"2025-10-29 06:12","pubTimestamp":1761689530,"startTime":"0","endTime":"0","summary":"BRIEF-Anteris Duravr THV Shows Favorable Hemodynamics In Small Annuli Patients With No Valve Mortality At One YearOct 28 (Reuters) - Anteris Technologies Global Corp AVR.O:ANTERIS DURAVR THV DEMONSTRA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W9266:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"2579131879","title":"Anteris Duravr® Thv Demonstrates Favorable Hemodynamics in Small Annuli Patients With No Valve Related Mortality at One Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2579131879","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579131879?lang=en_us&edition=fundamental","pubTime":"2025-10-29 06:08","pubTimestamp":1761689319,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W9266:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2579991313","title":"Anteris Technologies Reports Positive One-Year Results for DurAVR THV in Small Annuli Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2579991313","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579991313?lang=en_us&edition=fundamental","pubTime":"2025-10-29 06:08","pubTimestamp":1761689312,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp. has announced one-year clinical outcomes for its DurAVR Transcatheter Heart Valve  in patients with symptomatic severe aortic stenosis and small aortic annuli. The results, drawn from a pooled cohort of 65 patients enrolled in the ongoing EMBARK Study and US Early Feasibility Study , demonstrated sustained favorable hemodynamics, including a mean effective orifice area  of 2.1 ± 0.2 cm and a mean pressure gradient  of 8.6 ± 2.6 mmHg at one year. The study reported no valve-related mortality and no moderate or severe paravalvular leak at one year. Additionally, the rate of prosthesis-patient mismatch at 30 days was 1.5%, which is lower than rates reported for current commercial devices. These findings will be further evaluated in the ongoing global pivotal PARADIGM Trial , a prospective, randomized controlled trial comparing the DurAVR THV with commercially available transcatheter aortic valve replacements.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL5wcbdM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B3QW5Z07.USD","BK4585","IE00BKPKM429.USD","BK4082","BK4112","LU2210149790.SGD","IE00B64PRP62.GBP","LU0314104364.USD","LU2210150020.SGD","NDAQ","LU2095319765.USD","AVR","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2578606852","title":"BRIEF-Anteris Technologies Global Announces $25.2 Mln Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2578606852","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578606852?lang=en_us&edition=fundamental","pubTime":"2025-10-28 09:01","pubTimestamp":1761613291,"startTime":"0","endTime":"0","summary":"BRIEF-Anteris Technologies Global Announces $25.2 Mln Placement Oct 28 (Reuters) - Anteris Technologies Global Corp AVR.O:$25.2 MILLION PLACEMENT AT ISSUE PRICE $4.90 PER SHAREFurther company coverage: AVR.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W820T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2578605070","title":"Anteris Technologies Global Corp-Proposed Issue of Securities - Avr","url":"https://stock-news.laohu8.com/highlight/detail?id=2578605070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578605070?lang=en_us&edition=fundamental","pubTime":"2025-10-28 09:00","pubTimestamp":1761613206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nTUE3KSRBL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVR","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":83,"code":"91000000","status":"200"}]}}